(Q32026744)

English

Clarithromycin vs. furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Clarithromycin vs. furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Helicobacter pylori

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Helicobacter pylori infectious disease

1 reference

based on heuristic

inferred from title

Reza Malekzadeh

2

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Behrooz Z. Alizadeh

object named as

Alizadeh BZ

6

0 references

author name string

Fakheri H

1

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Merat S

3

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Khatibian M

4

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Fazel A

5

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Massarrat S

7

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

language of work or name

0 references

publication date

1 March 2001

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

411-416

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Does eradication of Helicobacter pylori alone heal duodenal ulcers?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00931.X

21 January 2018

Antibiotic-resistant H. pylori infection and its treatment

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00931.X

21 January 2018

Challenges to therapy in the future

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00931.X

21 January 2018

Strategy for treatment of Helicobacter pylori infection in adults. II. Practical policy in 2000.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00931.X

21 January 2018

Susceptibility of Campylobacter pylori to macrolides and fluoroquinolones.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00931.X

21 January 2018

Regional differences in metronidazole resistance and increasing clarithromycin resistance among Helicobacter pylori isolates from Japan

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00931.X

21 January 2018

Furazolidone combination therapies for Helicobacter pylori infection in the United States.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00931.X

21 January 2018

Omeprazole, clarithromycin and furazolidone for the eradication of Helicobacter pylori in patients with duodenal ulcer

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00931.X

21 January 2018

Treatment of Helicobacter pylori infection: a review of the world literature

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00931.X

21 January 2018

Resistance of Helicobacter pylori to antibiotics

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00931.X

21 January 2018

Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00931.X

21 January 2018

Helicobacter pylori eradication with lansoprazole, amoxycillin and clarithromycin: testing an ideal regimen in a multicultural south east Asian population and examining factors potentially influencing eradication

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00931.X

21 January 2018

Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00931.X

21 January 2018

Seven-day treatment for Helicobacter pylori infection: ranitidine bismuth citrate plus clarithromycin and tetracycline hydrochloride.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00931.X

21 January 2018

Eradication of Helicobacter pylori with clarithromycin and omeprazole

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00931.X

21 January 2018

Treatment of peptic ulcer disease with furazolidone

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00931.X

21 January 2018

In vitro selection of resistant Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00931.X

21 January 2018

Twice-daily, 10-day triple therapy with omeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in duodenal ulcer disease: results of three multicenter, double-blind, United States trials

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00931.X

21 January 2018

Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00931.X

21 January 2018

Furazolidone versus metronidazole in quadruple therapy for eradication of Helicobacter pylori in duodenal ulcer disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00931.X

21 January 2018

Randomized clinical trial comparing two one-week triple-therapy regimens for the eradication of Helicobacter pylori infection and duodenal ulcer healing

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00931.X

21 January 2018

Identifiers

10.1046/J.1365-2036.2001.00931.X

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q32026744&oldid=1978497089"